{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:44:47Z","timestamp":1782773087796,"version":"3.54.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"27","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,7,21]]},"DOI":"10.1038\/s41388-026-03841-6","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:46:36Z","timestamp":1780681596000},"page":"2743-2754","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FN1+ macrophages fuel aggressive sarcomatoid differentiation and immunotherapy refractory outcome in clear cell renal cell carcinoma"],"prefix":"10.1038","volume":"45","author":[{"given":"Jiangting","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youqi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8906-3773","authenticated-orcid":false,"given":"Siyuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9300-8401","authenticated-orcid":false,"given":"Jianming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7431-9063","authenticated-orcid":false,"given":"Jiejie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"3841_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur Urol. 2022;82:529\u201342.","journal-title":"Eur Urol"},{"key":"3841_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch H, Amin MB, Berney DM, Comp\u00e9rat EM, Gill AJ, Hartmann A, et al. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 2022;82:458\u201368.","journal-title":"Eur Urol"},{"key":"3841_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41585-020-00382-9","volume":"17","author":"KA Blum","year":"2020","unstructured":"Blum KA, Gupta S, Tickoo SK, Chan TA, Russo P, Motzer RJ, et al. Sarcomatoid renal cell carcinoma: biology, natural history and management. Nat Rev Urol. 2020;17:659\u201378.","journal-title":"Nat Rev Urol"},{"key":"3841_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-5347(05)65384-0","volume":"167","author":"BM Mian","year":"2002","unstructured":"Mian BM, Bhadkamkar N, Slaton JW, Pisters PW, Daliani D, Swanson DA, et al. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol. 2002;167:65\u201370.","journal-title":"J Urol"},{"key":"3841_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00000478-200103000-00001","volume":"25","author":"M de Peralta-Venturina","year":"2001","unstructured":"de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, et al. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surgical Pathol. 2001;25:275\u201384.","journal-title":"Am J Surgical Pathol"},{"key":"3841_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/003130299104945","volume":"31","author":"B Delahunt","year":"1999","unstructured":"Delahunt B. Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies. Pathology. 1999;31:185\u201390.","journal-title":"Pathology"},{"key":"3841_CR7","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","volume":"332","author":"TL Rose","year":"2024","unstructured":"Rose TL, Kim WY. Renal cell carcinoma: a review. JAMA. 2024;332:1001\u201310.","journal-title":"JAMA"},{"key":"3841_CR8","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","volume":"378","author":"RJ Motzer","year":"2018","unstructured":"Motzer RJ, Tannir NM, McDermott DF, Ar\u00e9n Frontera O, Melichar B, Choueiri TK, et al. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma. N Engl J Med. 2018;378:1277\u201390.","journal-title":"N Engl J Med"},{"key":"3841_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.6004\/jnccn.2024.0008","volume":"22","author":"RJ Motzer","year":"2024","unstructured":"Motzer RJ, Jonasch E, Agarwal N, Alva A, Bagshaw H, Baine M, et al. NCCN Guidelines\u00ae Insights: Kidney Cancer, Version 2.2024. J Natl Compr Cancer Netw JNCCN. 2024;22:4\u201316.","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"3841_CR10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.annonc.2024.05.537","volume":"35","author":"T Powles","year":"2024","unstructured":"Powles T, Albiges L, Bex A, Comperat E, Gr\u00fcnwald V, Kanesvaran R, et al. Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024;35:692\u2013706.","journal-title":"Ann Oncol"},{"key":"3841_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","volume":"82","author":"B Ljungberg","year":"2022","unstructured":"Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82:399\u2013410.","journal-title":"Eur Urol"},{"key":"3841_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41585-022-00676-0","volume":"20","author":"M Rosellini","year":"2023","unstructured":"Rosellini M, Marchetti A, Mollica V, Rizzo A, Santoni M, Massari F. Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma. Nat Rev Urol. 2023;20:133\u201357.","journal-title":"Nat Rev Urol"},{"key":"3841_CR13","doi-asserted-by":"publisher","first-page":"e484","DOI":"10.1634\/theoncologist.2019-0578","volume":"25","author":"DJ Martini","year":"2020","unstructured":"Martini DJ, Liu Y, Shabto JM, Carthon BC, Hitron EE, Russler GA, et al. Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. Oncologist. 2020;25:e484\u2013e91.","journal-title":"Oncologist"},{"key":"3841_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1470-2045(12)70559-4","volume":"14","author":"DY Heng","year":"2013","unstructured":"Heng DY, Xie W, Regan MM, Harshman LC, Bjarnason GA, Vaishampayan UN, et al. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. Lancet Oncol. 2013;14:141\u20138.","journal-title":"Lancet Oncol"},{"key":"3841_CR15","doi-asserted-by":"crossref","unstructured":"Grigg CM, Symanowski J. Re-Evaluating Established Prognostic Models in the Era of Immunotherapy in Renal Cell Carcinoma. JCO Oncol Pract. 2026;22:724\u20136.","DOI":"10.1200\/OP-25-00697"},{"key":"3841_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41573-021-00155-y","volume":"20","author":"SP Kubli","year":"2021","unstructured":"Kubli SP, Berger T, Araujo DV, Siu LL, Mak TW. Beyond immune checkpoint blockade: emerging immunological strategies. Nat Rev Drug Discov. 2021;20:899\u2013919.","journal-title":"Nat Rev Drug Discov"},{"key":"3841_CR17","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","volume":"42","author":"C Galassi","year":"2024","unstructured":"Galassi C, Chan TA, Vitale I, Galluzzi L. The hallmarks of cancer immune evasion. Cancer Cell. 2024;42:1825\u201363.","journal-title":"Cancer Cell"},{"key":"3841_CR18","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jord\u0101o MJC, Joyce JA. Therapeutic Targeting of the Tumor Microenvironment. Cancer Discov. 2021;11:933\u201359.","journal-title":"Cancer Discov"},{"key":"3841_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","volume":"19","author":"MJ Pittet","year":"2022","unstructured":"Pittet MJ, Michielin O, Migliorini D. Clinical relevance of tumour-associated macrophages. Nat Rev Clin Oncol. 2022;19:402\u201321.","journal-title":"Nat Rev Clin Oncol"},{"key":"3841_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ccell.2024.04.002","volume":"42","author":"C Bl\u00e9riot","year":"2024","unstructured":"Bl\u00e9riot C, Dunsmore G, Alonso-Curbelo D, Ginhoux F. A temporal perspective for tumor-associated macrophage identities and functions. Cancer cell. 2024;42:747\u201358.","journal-title":"Cancer cell"},{"key":"3841_CR21","doi-asserted-by":"publisher","first-page":"e23277","DOI":"10.1097\/MD.0000000000023277","volume":"99","author":"HJ An","year":"2020","unstructured":"An HJ, Koh HM, Lee JS, Song DH. Prognostic role of macrophage migration inhibitory factor in patients with clear cell renal cell carcinoma. Medicine. 2020;99:e23277.","journal-title":"Medicine"},{"key":"3841_CR22","doi-asserted-by":"publisher","first-page":"6400","DOI":"10.1158\/0008-5472.CAN-11-1261","volume":"71","author":"I Daurkin","year":"2011","unstructured":"Daurkin I, Eruslanov E, Stoffs T, Perrin GQ, Algood C, Gilbert SM, et al. Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway. Cancer Res. 2011;71:6400\u20139.","journal-title":"Cancer Res"},{"key":"3841_CR23","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/cas.12917","volume":"107","author":"C Ma","year":"2016","unstructured":"Ma C, Komohara Y, Ohnishi K, Shimoji T, Kuwahara N, Sakumura Y, et al. Infiltration of tumor-associated macrophages is involved in CD44 expression in clear cell renal cell carcinoma. Cancer Sci. 2016;107:700\u20137.","journal-title":"Cancer Sci"},{"key":"3841_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/acs.biomac.8b01258","volume":"20","author":"R Mezzenga","year":"2019","unstructured":"Mezzenga R, Mitsi M. The Molecular Dance of Fibronectin: Conformational Flexibility Leads to Functional Versatility. Biomacromolecules. 2019;20:55\u201372.","journal-title":"Biomacromolecules"},{"key":"3841_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ccr.2009.01.023","volume":"15","author":"C Kudo-Saito","year":"2009","unstructured":"Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer cell. 2009;15:195\u2013206.","journal-title":"Cancer cell"},{"key":"3841_CR26","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/35020106","volume":"406","author":"EA Clark","year":"2000","unstructured":"Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature. 2000;406:532\u20135.","journal-title":"Nature"},{"key":"3841_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1429","volume":"13","author":"X Huo","year":"2023","unstructured":"Huo X, Ma S, Wang C, Song L, Yao B, Zhu S, et al. Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma. Clin Transl Med. 2023;13:e1429.","journal-title":"Clin Transl Med"},{"key":"3841_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1158\/0008-5472.CAN-23-3803","volume":"84","author":"DE Michaud","year":"2024","unstructured":"Michaud DE, Guerriero JL. Myeloid Cells Pave the Metastatic Road in Breast Cancer. Cancer Res. 2024;84:181\u20133.","journal-title":"Cancer Res"},{"key":"3841_CR29","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184:792\u2013809.e23.","journal-title":"Cell"},{"key":"3841_CR30","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa2026982","volume":"384","author":"TK Choueiri","year":"2021","unstructured":"Choueiri TK, Powles T, Burotto M, Escudier B, Bourlon MT, Zurawski B, et al. Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma. N Engl J Med. 2021;384:829\u201341.","journal-title":"N Engl J Med"},{"key":"3841_CR31","doi-asserted-by":"crossref","unstructured":"Qiu Y, Liu L, Jiang W, Xu Z, Wang J, Dai S, et al. NKG2A(+)CD8(+) T cells infiltration determines immunosuppressive contexture and inferior response to immunotherapy in clear cell renal cell carcinoma. J Immunotherapy Cancer. 2024;12:e008368.","DOI":"10.1136\/jitc-2023-008368"},{"key":"3841_CR32","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","volume":"373","author":"RJ Motzer","year":"2015","unstructured":"Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S, et al. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. N Engl J Med. 2015;373:1803\u201313.","journal-title":"N Engl J Med"},{"key":"3841_CR33","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s41591-020-0839-y","volume":"26","author":"DA Braun","year":"2020","unstructured":"Braun DA, Hou Y, Bakouny Z, Ficial M, Sant\u2019 Angelo M, Forman J, et al. Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma. Nat Med. 2020;26:909\u201318.","journal-title":"Nat Med"},{"key":"3841_CR34","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41591-018-0053-3","volume":"24","author":"DF McDermott","year":"2018","unstructured":"McDermott DF, Huseni MA, Atkins MB, Motzer RJ, Rini BI, Escudier B, et al. Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. Nat Med. 2018;24:749\u201357.","journal-title":"Nat Med"},{"key":"3841_CR35","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ccell.2021.02.013","volume":"39","author":"DA Braun","year":"2021","unstructured":"Braun DA, Street K, Burke KP, Cookmeyer DL, Denize T, Pedersen CB, et al. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma. Cancer Cell. 2021;39:632\u201348.e8.","journal-title":"Cancer Cell"},{"key":"3841_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26091-4","volume":"12","author":"MC Kim","year":"2021","unstructured":"Kim MC, Borcherding N, Ahmed KK, Voigt AP, Vishwakarma A, Kolb R, et al. CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells. Nat Commun. 2021;12:5764.","journal-title":"Nat Commun"},{"key":"3841_CR37","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.ccell.2021.03.007","volume":"39","author":"C Krishna","year":"2021","unstructured":"Krishna C, DiNatale RG, Kuo F, Srivastava RM, Vuong L, Chowell D, et al. Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy. Cancer Cell. 2021;39:662\u201377.e6.","journal-title":"Cancer Cell"},{"key":"3841_CR38","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1016\/j.cell.2021.04.038","volume":"184","author":"A Obradovic","year":"2021","unstructured":"Obradovic A, Chowdhury N, Haake SM, Ager C, Wang V, Vlahos L, et al. Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages. Cell. 2021;184:2988\u20133005.e16.","journal-title":"Cell"},{"key":"3841_CR39","doi-asserted-by":"crossref","unstructured":"Zhang Y, Narayanan SP, Mannan R, Raskind G, Wang X, Vats P, et al. Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response. Proc Natl Acad Sci USA. 2021;118:e2103240118.","DOI":"10.1073\/pnas.2103240118"},{"key":"3841_CR40","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.ccell.2022.11.001","volume":"40","author":"R Li","year":"2022","unstructured":"Li R, Ferdinand JR, Loudon KW, Bowyer GS, Laidlaw S, Muyas F, et al. Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer. Cancer Cell. 2022;40:1583\u201399.e10.","journal-title":"Cancer Cell"},{"key":"3841_CR41","doi-asserted-by":"crossref","unstructured":"Chow J, Khan A, Gaudieri M, Wasik BJ, Conway A, Soh KT, et al. Tumor and immune remodeling following radiotherapy in human renal cell carcinoma. J Immunotherapy Cancer. 2023;11:e006392.","DOI":"10.1136\/jitc-2022-006392"},{"key":"3841_CR42","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.eururo.2023.02.008","volume":"83","author":"JR Saout","year":"2023","unstructured":"Saout JR, Lecuyer G, L\u00e9onard S, Evrard B, Kammerer-Jacquet SF, No\u00ebl L, et al. Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma Patients. Eur Urol. 2023;83:441\u201351.","journal-title":"Eur Urol"},{"key":"3841_CR43","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1158\/0008-5472.CAN-22-2224","volume":"83","author":"Z Yu","year":"2023","unstructured":"Yu Z, Lv Y, Su C, Lu W, Zhang R, Li J, et al. Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma. Cancer Res. 2023;83:700\u201319.","journal-title":"Cancer Res"},{"key":"3841_CR44","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42:293\u2013304.","journal-title":"Nat Biotechnol"},{"key":"3841_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. Gene Ontol Consort Nat Genet. 2000;25:25\u20139.","journal-title":"Gene Ontol Consort Nat Genet"},{"key":"3841_CR46","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3841_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinf. 2013;14:7.","journal-title":"BMC Bioinf"},{"key":"3841_CR48","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","volume":"55","author":"M Meylan","year":"2022","unstructured":"Meylan M, Petitprez F, Becht E, Bougo\u00fcin A, Pupier G, Calvez A, et al. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity. 2022;55:527\u201341.e5.","journal-title":"Immunity"},{"key":"3841_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41421-025-00829-6","volume":"11","author":"G Shan","year":"2025","unstructured":"Shan G, Bian Y, Sui Q, Liang J, Ren S, Pan B, et al. Ferroptosis-induced SUMO2 lactylation counteracts ferroptosis by enhancing ACSL4 degradation in lung adenocarcinoma. Cell Discov. 2025;11:81.","journal-title":"Cell Discov"},{"key":"3841_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.970","volume":"12","author":"Z Li","year":"2022","unstructured":"Li Z, Xu H, Yu L, Wang J, Meng Q, Mei H, et al. Patient-derived renal cell carcinoma organoids for personalized cancer therapy. Clin Transl Med. 2022;12:e970.","journal-title":"Clin Transl Med"},{"key":"3841_CR51","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.humpath.2011.06.019","volume":"43","author":"AK Bostrom","year":"2012","unstructured":"Bostrom AK, Moller C, Nilsson E, Elfving P, Axelson H, Johansson ME. Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition. Hum Pathol. 2012;43:708\u201319.","journal-title":"Hum Pathol"},{"key":"3841_CR52","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S, et al. Identification of the tumour transition states occurring during EMT. Nature. 2018;556:463\u20138.","journal-title":"Nature"},{"key":"3841_CR53","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccr.2014.03.021","volume":"25","author":"S Su","year":"2014","unstructured":"Su S, Liu Q, Chen J, Chen J, Chen F, He C, et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell. 2014;25:605\u201320.","journal-title":"Cancer Cell"},{"key":"3841_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0976-4","volume":"18","author":"C Wei","year":"2019","unstructured":"Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, et al. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Mol Cancer. 2019;18:64.","journal-title":"Mol Cancer"},{"key":"3841_CR55","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.addr.2020.09.005","volume":"170","author":"J Patten","year":"2021","unstructured":"Patten J, Wang K. Fibronectin in development and wound healing. Adv Drug Deliv Rev. 2021;170:353\u201368.","journal-title":"Adv Drug Deliv Rev"},{"key":"3841_CR56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40164-022-00260-7","volume":"11","author":"Z Qin","year":"2022","unstructured":"Qin Z, Zhou C. HOXA13 promotes gastric cancer progression partially via the FN1-mediated FAK\/Src axis. Exp Hematol Oncol. 2022;11:7.","journal-title":"Exp Hematol Oncol"},{"key":"3841_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07307-3","volume":"23","author":"M Udinotti","year":"2025","unstructured":"Udinotti M, Siebolts U, Bauer M, Vaxevanis C, Asiminas A, Lorenz K, et al. Fibroblast activation protein (FAP)-mediated promotion of metastasis via the FN1-TGF\u03b2 axis and immune suppression in aggressive thyroid cancer. J Transl Med. 2025;23:1284.","journal-title":"J Transl Med"},{"key":"3841_CR58","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1038\/s41388-025-03359-3","volume":"44","author":"W Chen","year":"2025","unstructured":"Chen W, Jiang M, Zou X, Chen Z, Shen L, Hu J, et al. Fibroblast Activation Protein (FAP)(+) cancer-associated fibroblasts induce macrophage M2-like polarization via the Fibronectin 1-Integrin \u03b15\u03b21 axis in breast cancer. Oncogene. 2025;44:2396\u2013412.","journal-title":"Oncogene"},{"key":"3841_CR59","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.annonc.2025.06.014","volume":"36","author":"KC K\u00e4hler","year":"2025","unstructured":"K\u00e4hler KC, Hassel JC, Ziemer M, Rutkowski P, Meier F, Flatz L, et al. Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma. Ann Oncol. 2025;36:1166\u201377.","journal-title":"Ann Oncol"},{"key":"3841_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100929","volume":"67","author":"J Jin","year":"2023","unstructured":"Jin J, Xie Y, Zhang JS, Wang JQ, Dai SJ, He WF, et al. Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers. Drug Resist Updates. 2023;67:100929.","journal-title":"Drug Resist Updates"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03841-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03841-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03841-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:01:41Z","timestamp":1782770501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03841-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":60,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2026,7,21]]}},"alternative-id":["3841"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03841-6","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"24 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known conflict of interest or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in full accordance with relevant ethical principles and guidelines. The experimental procedures were handled according to the guidelines of Zhongshan Hospital Ethics Committee. Ethical approval was granted by the Ethics Committee of Zhongshan Hospital (No. B2024-101), and informed consent was obtained from all patients or their relatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}